These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The Structural Interface between HIV-1 Vif and Human APOBEC3H. Ooms M; Letko M; Simon V J Virol; 2017 Mar; 91(5):. PubMed ID: 28031368 [TBL] [Abstract][Full Text] [Related]
8. The localization of APOBEC3H variants in HIV-1 virions determines their antiviral activity. Ooms M; Majdak S; Seibert CW; Harari A; Simon V J Virol; 2010 Aug; 84(16):7961-9. PubMed ID: 20519396 [TBL] [Abstract][Full Text] [Related]
9. RNA-Mediated Dimerization of the Human Deoxycytidine Deaminase APOBEC3H Influences Enzyme Activity and Interaction with Nucleic Acids. Feng Y; Wong L; Morse M; Rouzina I; Williams MC; Chelico L J Mol Biol; 2018 Dec; 430(24):4891-4907. PubMed ID: 30414963 [TBL] [Abstract][Full Text] [Related]
10. Mapping Region of Human Restriction Factor APOBEC3H Critical for Interaction with HIV-1 Vif. Nakashima M; Tsuzuki S; Awazu H; Hamano A; Okada A; Ode H; Maejima M; Hachiya A; Yokomaku Y; Watanabe N; Akari H; Iwatani Y J Mol Biol; 2017 Apr; 429(8):1262-1276. PubMed ID: 28336404 [TBL] [Abstract][Full Text] [Related]
11. The resistance of human APOBEC3H to HIV-1 NL4-3 molecular clone is determined by a single amino acid in Vif. Ooms M; Letko M; Binka M; Simon V PLoS One; 2013; 8(2):e57744. PubMed ID: 23469063 [TBL] [Abstract][Full Text] [Related]
12. The Antiviral and Cancer Genomic DNA Deaminase APOBEC3H Is Regulated by an RNA-Mediated Dimerization Mechanism. Shaban NM; Shi K; Lauer KV; Carpenter MA; Richards CM; Salamango D; Wang J; Lopresti MW; Banerjee S; Levin-Klein R; Brown WL; Aihara H; Harris RS Mol Cell; 2018 Jan; 69(1):75-86.e9. PubMed ID: 29290613 [TBL] [Abstract][Full Text] [Related]
13. HIV-1 competition experiments in humanized mice show that APOBEC3H imposes selective pressure and promotes virus adaptation. Nakano Y; Misawa N; Juarez-Fernandez G; Moriwaki M; Nakaoka S; Funo T; Yamada E; Soper A; Yoshikawa R; Ebrahimi D; Tachiki Y; Iwami S; Harris RS; Koyanagi Y; Sato K PLoS Pathog; 2017 May; 13(5):e1006348. PubMed ID: 28475648 [TBL] [Abstract][Full Text] [Related]
14. Recurrent Loss of APOBEC3H Activity during Primate Evolution. Garcia EI; Emerman M J Virol; 2018 Sep; 92(17):. PubMed ID: 29925657 [TBL] [Abstract][Full Text] [Related]
15. The DNA cytosine deaminase APOBEC3H haplotype I likely contributes to breast and lung cancer mutagenesis. Starrett GJ; Luengas EM; McCann JL; Ebrahimi D; Temiz NA; Love RP; Feng Y; Adolph MB; Chelico L; Law EK; Carpenter MA; Harris RS Nat Commun; 2016 Sep; 7():12918. PubMed ID: 27650891 [TBL] [Abstract][Full Text] [Related]
17. Analysis of human APOBEC3H haplotypes and anti-human immunodeficiency virus type 1 activity. Wang X; Abudu A; Son S; Dang Y; Venta PJ; Zheng YH J Virol; 2011 Apr; 85(7):3142-52. PubMed ID: 21270145 [TBL] [Abstract][Full Text] [Related]
18. Polymorphism in human APOBEC3H affects a phenotype dominant for subcellular localization and antiviral activity. Li MM; Emerman M J Virol; 2011 Aug; 85(16):8197-207. PubMed ID: 21653666 [TBL] [Abstract][Full Text] [Related]
19. Natural Polymorphisms and Oligomerization of Human APOBEC3H Contribute to Single-stranded DNA Scanning Ability. Feng Y; Love RP; Ara A; Baig TT; Adolph MB; Chelico L J Biol Chem; 2015 Nov; 290(45):27188-27203. PubMed ID: 26396192 [TBL] [Abstract][Full Text] [Related]
20. APOBEC3H polymorphisms associated with the susceptibility to HIV-1 infection and AIDS progression in Japanese. Sakurai D; Iwatani Y; Ohtani H; Naruse TK; Terunuma H; Sugiura W; Kimura A Immunogenetics; 2015 Apr; 67(4):253-7. PubMed ID: 25721876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]